Omalizumab in idiopathic anaphylaxis

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 3, 2009, Pages 257-258

  Warrier, P ^a   Casale, T B ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN E; OMALIZUMAB;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANAPHYLAXIS; CASE REPORT; CHILD; DAILY LIFE ACTIVITY; DISEASE EXACERBATION; FOOD ALLERGY; FORCED EXPIRATORY VOLUME; HUMAN; IDIOPATHIC DISEASE; LETTER; MALE; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; SCHOOL CHILD; TREATMENT RESPONSE;

EID: 63449091003     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60091-9     Document Type: Letter

References (7)

1. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005; 115(suppl 2):S483-S523.
2. Patterson R, Hogan MB, Yarnold PR, Harris KE. Idiopathic anaphylaxis: an attempt to estimate the incidence in the United States. Arch Intern Med. 1995;155: 869-871.
3. Moneret-Vautrin DA. Idiopathic anaphylaxis. Eur Ann Allergy Clin Immunol. 2004;36:13-19.
4. Simons FE. 9. Anaphylaxis. J Allergy Clin Immunol. 2008;121(suppl 2): S402-S407.
5. Greenberger PA. Idiopathic anaphylaxis. Immunol Allergy Clin North Am. 2007; 27:273-293.
6. Casale TB, Stokes JR. Immunomodulators for allergic respiratory disorders. J Allergy Clin Immunol. 2008;121:288-296.
7. Chang TW, Shiung Yu-Y. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol. 2006;117:1203-1212.